RPS6KB1 and liver cancer: Further in vivo and in vitro studies demonstrated that exogenous overexpression of AIM2 inhibited malignancies of HCC cells through suppressing mTOR-S6K1 pathway, which suggested a protective role of AIM2 against liver cancers.